Insta
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Representative Image
Bharat Biotech has obtained the approval from the Drugs Comptroller General of India (DCGI) for carrying out last-stage trials of its nasal Covid-19 vaccine as a form of booster shots, reports Moneycontrol.
The company had filed its last-stage trial application to the DCGI back in December as it maintained that there would be greater convenience in administering an intranasal vaccine during the mass vaccination campaign.
The drug regulator’s subject expert committee (SEC) has reportedly given an in-principle to Bharat Biotech for conducting the intranasal vaccine’s ‘Phase III superiority study and Phase III booster dose study’ in parallel in wake of the Covid situation in the country.
The development comes as the government had recently announced that Healthcare and frontline workers along with the elderly citizens will receive a ‘precautionary dose’ or a booster shot of the Covid-19 vaccine from 10th January onwards.
So far, Covishield manufactured by the Serum Institute of India (SII) along with Bharat Biotech’s Covaxin have largely dominated the massive vaccination drive carried out in India.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
